For the first time, a compound developed at the Milwaukee Institute for Drug Discovery (MIDD) will enter clinical trials at the U.S. Food and Drug Administration. The drug was developed in part by distinguished professor emeritus Jim Cook of the Chemistry & Biochemistry Department. Read the article here.